Metabolism of prostaglandins in human saphenous vein

This publication has 25 references indexed in Scilit:

• Prevention of lipid accumulation in experimental vein bypass grafts by antiplatelet therapy.
  Circulation, 1982
• A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations
  New England Journal of Medicine, 1982
• Coronary Vasoconstrictor Effect of Indomethacin in Patients with Coronary-Artery Disease
  New England Journal of Medicine, 1981
• Prostaglandin endoperoxide metabolism by bovine cerebral micro vessels
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
• Pathological Changes in Aortocoronary Bypass Grafts
  Annual Review of Medicine, 1980
• Purification and characterisation of prostaglandin endoperoxide D-isomerase, a cytoplasmic, glutathione-requiring enzymE
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
• Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendothelium
  Prostaglandins, 1978
• Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium
  Thrombosis Research, 1977
• HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
  The Lancet, 1977
• Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
  Prostaglandins, 1976